SOLCF - SOL Global Investments Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

SOL Global Investments Corp.

100 King Street West
Suite 5600
Toronto, ON M5X 1C9

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Brady CobbInterim Chairman & CEON/AN/AN/A
Mr. Peter D. Liabotis CPA, CAChief Financial OfficerN/AN/A1970
Mr. Adam WilksChief Operating OfficerN/AN/AN/A
Mr. Maghsoud DarianiChief Scientific OfficerN/AN/A1953
Prof. Michael BarnesChief Medical OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


SOL Global Investments Corp. operates as an investment company with a focus on the cannabis industry in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018. SOL Global Investments Corp. is based in Toronto, Canada.

Corporate Governance

SOL Global Investments Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.